77% |
With hydrogenchloride; In 1,4-dioxane; at 80℃; for 1h; |
General procedure: A solution of 1 or 2 (each 5.0mg) in 1M HCl-1,4-dioxiane(1:1, v/v, 1.0mL) was stirred at 80C for 1h.After cooling, the reaction mixture was neutralized withAmberlite IRA-400 (OH- form) and the resin was removedby filtration. After removal of the solvent from the filtrateunder reduced pressure, the residue was partitioned inEtOAc-H2O (1:1, v/v), and the solvents removed in vacuofrom the EtOAc-soluble fraction and an aqueous phase,respectively. The EtOAc-soluble fraction was purifiedby normal-phase silica gel CC [500mg, hexane-EtOAc(3:1, v/v)] to furnish 3-O-methylellagic acid (1a, 2.8mg,78%, from 1) [12] or ellagic acid (8, 2.0mg, 77% from 2)[12, 23, 25, 26]. In turn, the aqueous layer was subjectedto HPLC analysis under the following conditions: HPLC column, Kaseisorb LC NH2-60-5, 4.6mm i.d.×250mm(Tokyo Kasei Co., Ltd.); detection, optical rotation [ShodexOR-2 (Showa Denko Co., Ltd., Tokyo, Japan); mobilephase, CH3CN-H2O (85:15, v/v); flow rate 0.5mL/min]. Identification of L-rhamnose [tR: 12.0min (negative optical rotation)] from 2 and L-arabinose [tR: 16.2min (positive optical rotation)] from 1 and 2 in the H2O-elutedfraction was carried out by comparing the retention timeand optical rotation with those of authentic samples [1,13-21]. Through a similar procedure, 1a [3.0mg, 85%from 5 (5.0mg)], 3,3?-di-O-methylellagic acid [1c, 1.9mg,88% from 1b (3.0mg)] [12, 23], 4,3?-di-O-methylellagicacid [2b, 1.0mg, 88% from 2a (2.0mg)] [26], 4,3?,4?-tri-O-methylellagic acid [3b, 1.0mg, 73% from 3a (2.0mg)][23, 27], and 8 [2.9mg, 86% from 3 (5.0mg)] were purifiedfrom each EtOAc-soluble fraction by normal-phasesilica gel CC. |